462 125 mg
Generic Name: aprepitant
Pill imprint 462 125 mg has been identified as Emend 125 mg.
Emend is used in the treatment of nausea/vomiting, chemotherapy induced; nausea/vomiting, postoperative and belongs to the drug class miscellaneous antiemetics. There is no proven risk in humans during pregnancy.
Emend 125 mg is not subject to the Controlled Substances Act.
See also related documents.
Emend Images
- Generic Name:
- aprepitant
- Imprint:
-
462 125 mg
- Strength:
- 125 mg
- Color:
- Pink & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- sucrose
microcrystalline cellulose
hydroxypropyl cellulose
sodium lauryl sulfate
gelatin
titanium dioxide
silicon dioxide
ferric oxide red
ferric oxide yellow
- Drug Class:
- Miscellaneous antiemetics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Merck & Company Inc.
- National Drug Code (NDC):
- 00006-0462


